← Back to Search

Ageless Grace for Stroke (CAPS Trial)

N/A
Recruiting
Led By gregory t thielman, EdD
Research Sponsored by University of the Sciences in Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up effects of a 3 day baseline walking average (prior to the 24 sessions at 2x/wk) compared to a 3 day walking average post training
Awards & highlights

CAPS Trial Summary

This trial will last 8 weeks and you will be asked to come in for testing and exercise classes 2 days a week. A step counter will be attached to your ankle for one week and you will be asked to wear it at all times. After the 8 weeks, you will be asked questions about any falls you may have had in the past 6 months.

Eligible Conditions
  • Stroke
  • Cognitive Impairment
  • Neuroplasticity
  • Exercise Intervention
  • Dual Tasking

CAPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~effects of a 3 day baseline walking average (prior to the 24 sessions at 2x/wk) compared to a 3 day walking average post training
This trial's timeline: 3 weeks for screening, Varies for treatment, and effects of a 3 day baseline walking average (prior to the 24 sessions at 2x/wk) compared to a 3 day walking average post training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary purpose is to determine the impact of a low intensity seated exercise program (24 sessions 2x/wk for 12 weeks) with cognitive training on dual task cognitive/motor function in individuals post stroke compared to age matched older adults
Secondary outcome measures
The secondary objectives are to determine the effects of the exercise program on walking activity (steps per day) for all enrolled subjects, while at home & in the community; as a result of the 24 training sessions

CAPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Subjects Post StrokeExperimental Treatment1 Intervention
Individuals post stroke have recently participated in this ongoing investigation in a live format but these subjects are now entered into a telehealth arm.
Group II: Health Older AdultsActive Control1 Intervention
This subset of subject's have a fair history with this methodology and are being used as the comparator.

Find a Location

Who is running the clinical trial?

University of the Sciences in PhiladelphiaLead Sponsor
13 Previous Clinical Trials
769 Total Patients Enrolled
1 Trials studying Stroke
24 Patients Enrolled for Stroke
gregory t thielman, EdDPrincipal InvestigatorUSciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are enrolled in this clinical research experiment?

"Affirmative. According to clinicaltrials.gov, the study was first made available on May 20th 2020 and has been recently revised on May 22nd 2022. The trial is currently recruiting 20 patients from a single medical centre."

Answered by AI

Are trial participants being accepted at this time for the clinical study?

"Affirmative. As per the information located on clinicaltrials.gov, this research is currently in search of participants; initially posted on May 20th 2020 and last updated on May 22nd 2022. The trial requires a total of 20 applicants at one study site."

Answered by AI
Recent research and studies
~4 spots leftby Apr 2025